Guest Keynote Speakers:

DR. JACKIE BENDER
Research Scientist
Prostate Cancer Support
Princess Margaret Hospital
Her focus will be on impact of peer support during diagnosis and treatment.

Dr. Jackie Bender is a Scientist in the Cancer Rehabilitation and Survivorship Program in the Department of Supportive Care at the Princess Margaret Cancer Centre, and an Assistant Professor in the Dalla Lana School of Public Health, and the Institute for Health Policy Management and Evaluation, at the University of Toronto. She has an innovative program of research in digital health, cancer survivorship and implementation science.

Her research focuses on designing, implementing and evaluating ways to improve the health and health care experience of people affected by cancer through the use of peer support and information and communication technologies. Funded by Movember and Prostate Cancer Canada, Dr. Bender co-leads the TrueNTH Peer Navigation program for men with prostate cancer and their partners. Dr. Bender has received numerous awards for her work including most recently, Best Research Paper from the prestigious International Medical Informatics Association.

JANACE KING-WATSON
Clinical Social Worker
Principal at King-Watson & Associates
Her focus will be on Mindfulness and its impact on healing cancer patients.

Janace King-Watson is a mental health professional and mediator with thirty years experience working in the field.  She held critical roles such as Psychiatric Social Worker and Crisis Intervention Specialist in the emergency room at Peel Memorial Hospital and the Mississauga Hospital. She has also worked in private practice and as a  Clinical Investigator and Mediator with The Office of the Children’s Lawyer.

Janace has been the keynote speaker to large and small audiences on topics such as mental health, separation and divorce, family violence and student success.  In addition, she has been the MC at numerous events over the years.

Janace holds a Specialized Honors degree in Psychology from York University and a Master of Social Work (with a specialty in Mediation).  She also holds a certificate in Women’s Studies from Harvard University School of Continuing Education.

DR. ANDREW MATTHEW
PhD, CPsych

Psychologist Sexual Health Support
Princess Margaret Cancer Centre
His focus will be on Sexual health after prostate cancer diagnosis and treatment.

Dr. Andrew Matthew is a senior staff Psychologist at Princess Margaret Cancer Centre. He is a Clinician-Investigator in the Department of Surgery, Division of Urology, a member of the Department of Supportive Care, and Co-Lead of the Genito-Urinary Survivorship Program. He is also an Associate Professor in the Faculty of Medicine, University of Toronto, in the Departments of Surgery and Psychiatry.

For the past 20 years, Andrew has worked in clinical and health psychology. His current clinical/research focus involves urologic cancers and includes prevention, treatment decision-making, sexual rehabilitation, survivorship and patient quality of life.

DR. WILL UNDERWOOD
Urologist
Buffalo NY
His focus will be on Prostate Cancer in African American and Caribbean men. He is also a cancer survivor.

Willie Underwood, III, MD, Msc, MPH is a urologist based in Buffalo, New York, and is a member of the Board of Trustees of the American Medical Association (AMA)

A board-certified urologic surgeon specializing in prostate cancer, Dr. Underwood has been an active leader in organized medicine for many years. He has chaired the AMA Council on Legislation and the AMA Resident and Fellow Section, and served as President of the Erie County New York Medical Society.

He has received several awards and honors. He received AUA Rising Star Award, Robert Wood Johnson Harold Amos Medical Career Development Award, just to name a few. His research interests include, but are not limited to, racial disparities in the diagnosis, treatment, and survival of urologic cancers. He has received independent R01 and U54 funding from NIH/NCI to study race, prostate cancer treatment and treatment decision difficulty and regret and to establish the Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities. He has co-authored over 100 peer review publications, published abstracts and book chapters.

DR. DANNY VESPRINI
Clinical Investigator
Odette Cancer Centre
His focus will be on Genetic risk factors for prostate cancer development (BRCA mutation carriers, African and Caribbean descent, family history.

Dr. Danny Vesprini is a Radiation Oncologist who treats both prostate and breast cancer at the Sunnybrook Odette Cancer Centre in Toronto, Affiliate Scientist in the Biological Sciences at the Sunnybrook Research Institute and an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. Dr Vesprini’s research includes a focus on the genetic predisposition to aggressive prostate cancer.

He is one of the Principal Investigators of the Sunnybrook Active Surveillance Program as well as the Director of the Male Oncology Research and Education (MORE) program which focusses on men at increased risk of developing prostate cancer, including men of with a strong family history of the disease, men with a BRCA mutation and men of Caribbean/Western African heritage. When Dr Vesprini goes home, he remembers that he is married to an incredibly understanding and patient wife with whom he shares 2 perfect children.

EFTHYMIOS PAPADOPOULOS, MSc
Registered Kinesiologist
Wellspring Cancer Network
His focus will be on the effects of physical activity and high-intensity training on clinical, physiological, and psychosocial outcomes in men with prostate cancer on active surveillance.

Efthymios Papadopoulos, is a PhD candidate in the Faculty of Kinesiology and Physical Education at the University of Toronto. He is also a Registered Kinesiologist at Wellspring Cancer Network, where he delivers exercise programs for cancer survivors. His research focuses on the effects of physical activity and high-intensity training on clinical, physiological, and psychosocial outcomes in men with prostate cancer on active surveillance.

This Event Is Sponsored By: